Date published: 2025-10-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

MIRA-1 (CAS 72835-26-8)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
1-[(1-Oxopropoxy)methyl]-1H-pyrrole 2,5-dione
Application:
MIRA-1 is a restorer of wild-type p53 conformation and cellular function
CAS Number:
72835-26-8
Purity:
≥95%
Molecular Weight:
183.16
Molecular Formula:
C8H9NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

MIRA-1, scientifically known as 1-[(1-Oxopropoxy)methyl]-1H-pyrrole 2,5-dione, is an organic compound extensively employed in scientific research due to its diverse range of applications. This compound is derived from pyrrole, a five-membered heterocyclic compound, and consists of a propionate group and a 2,5-dioxopyrrolidine ring with a methyl group attached. Its versatility has led to its utilization in various scientific research investigations, uncovering its manifold biochemical and physiological effects. Numerous studies have explored the effects of MIRA-1 on cellular processes such as cell proliferation and apoptosis. Additionally, investigations have focused on assessing the compound′s impact on biochemical and physiological phenomena like inflammation and oxidative stress. MIRA-1 has shown potential in modulating these processes. MIRA-1 exhibits the ability to reinstate the native structure, functionality, and DNA binding capacity of mutant p53. It triggers p53-mediated transcriptional activation of critical targets such as p21, MDM2, and PUMA. In vitro experiments have demonstrated that MIRA-1 elicits apoptosis in tumor cells, specifically in a mutant p53-dependent manner, with an observed IC50 value of 10μM. The exact mechanism of action underlying MIRA-1′s effects is not yet fully elucidated. However, it is postulated to function as an antioxidant, effectively scavenging reactive oxygen species, and as an anti-inflammatory agent, inhibiting the production of pro-inflammatory cytokines. These actions contribute to its potential benefits in various biological applications.


MIRA-1 (CAS 72835-26-8) References

  1. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.  |  Klingel, R., et al. 2003. Transfus Apher Sci. 29: 71-84. PMID: 12877897
  2. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD).  |  Pulido, J., et al. 2005. J Clin Apher. 20: 185-94. PMID: 15892078
  3. Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action.  |  Pulido, JS., et al. 2005. Can J Ophthalmol. 40: 332-40. PMID: 15947803
  4. Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs.  |  Bykov, VJ., et al. 2005. J Biol Chem. 280: 30384-91. PMID: 15998635
  5. Strategies for therapeutic targeting of the p53 pathway in cancer.  |  Wiman, KG. 2006. Cell Death Differ. 13: 921-6. PMID: 16557267
  6. p53 in breast cancer: mutation and countermeasures.  |  Kumar, S., et al. 2007. Front Biosci. 12: 4168-78. PMID: 17485365
  7. Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.  |  Aggarwal, M., et al. 2011. Proc Natl Acad Sci U S A. 108: 1525-30. PMID: 21220316
  8. Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents.  |  Saha, MN., et al. 2014. Br J Cancer. 110: 2224-31. PMID: 24691427
  9. p53 Family and Cellular Stress Responses in Cancer.  |  Pflaum, J., et al. 2014. Front Oncol. 4: 285. PMID: 25374842
  10. TP53: an oncogene in disguise.  |  Soussi, T. and Wiman, KG. 2015. Cell Death Differ. 22: 1239-49. PMID: 26024390
  11. The role of p53 in cancer drug resistance and targeted chemotherapy.  |  Hientz, K., et al. 2017. Oncotarget. 8: 8921-8946. PMID: 27888811

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

MIRA-1, 10 mg

sc-204087
10 mg
$116.00

MIRA-1, 50 mg

sc-204087A
50 mg
$443.00

Is sc-204087 synthetic or is it derived from a biological source?

Asked by: ChemSynth123
Thank you for your question. MIRA-1 (CAS 72835-26-8): sc-204087 is synthetic and not derived from a biological source.
Answered by: Chemical Support 7
Date published: 2017-03-03
  • y_2025, m_10, d_24, h_8CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_204087, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 104ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Bykov et alBykov et al. (PubMed ID 15998635) found that MIRA-3 showed antitumor activity in vivo against human mutant p53-carrying tumor xenografts in SCID mice. -SCBT Publication Review
Date published: 2015-07-13
  • y_2025, m_10, d_24, h_8
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204087, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 14ms
  • REVIEWS, PRODUCT
MIRA-1 is rated 5.0 out of 5 by 1.
  • y_2025, m_10, d_24, h_8
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204087, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 119ms
  • REVIEWS, PRODUCT